secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001654954-22-008381
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica appoints Anthony K. Blair as COO and Karen DeHaan-Fullerton as Chief Counsel
--------------------------------------------------------------------------------

- Anthony K. Blair appointed COO effective June 13, 2022; base salary $250K with up to 35% annual performance bonus.
- Karen DeHaan-Fullerton appointed Chief Counsel and Corporate Secretary; base salary $250K with up to 30% annual bonus.
- Blair previously EVP Operations since Jan 2022; prior roles include COO of Cardiox and VP at Neoprobe.
- DeHaan-Fullerton had been General Counsel since May 2022; prior experience at Exactech and Elanco.
- Both retain previously granted stock options (Blair: 3M shares at $0.35; DeHaan-Fullerton: 500K at $0.24) with four-year vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495422008381/0001654954-22-008381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495422008381/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-008381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer